ADVISORY, Feb. 20, 2007 (PRIME NEWSWIRE) --
What: Eli Hurvitz, Chairman of the Board of Teva Pharmaceutical Industries, Ltd., Israel Makov, President and CEO, Dan S. Suesskind CFO, and Mr. Shlomo Yanai, designated President and CEO, will preside over the opening bell. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Wednesday, February 21, 2007 at 9:30 a.m. ET Contacts: Ayala Miller Teva Pharmaceutical Industries, Ltd. 972.3.926.7262; firstname.lastname@example.org NASDAQ MarketSite: Jolene Libretto; 646.441.5220; mobile - 347.219.9539 Jolene.Libretto@NASDAQ.com
The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.
A live Webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
Teva Pharmaceutical Industries, Inc. (TEVA)
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.
In This StoryNDAQ
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.